Investigation of Parvovirus B19 Seroprevalence, Endothelin-1 Synthesis, and Nitric Oxide Levels in the Etiology of Essential Hypertension

REFERENCES

• Pierdomenico SD, Di Nicola M, Esposito AL, . Prognostic value of different indices of blood pressure variability in hypertensive patients. Am J Hypertens 2009; 22:842–847.
   PubMed Web of Science ®Google Scholar
• Mancia G, Laurent S, Agabiti-Rosei E, . Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27:2121–2158.
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones D, Adams R, Carnethon M, . Heart disease and stroke statistics – 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119:480–486.
   PubMed Web of Science ®Google Scholar
• Stumpf C, John S, Jukic J, . Enhanced levels of platelet P-selectin and circulating cytokines in young patients with mild arterial hypertension. J Hypertens 2005; 23:995–1000.
   PubMed Web of Science ®Google Scholar
• Spieker LE, Flammer AJ, Lüscher TF. The vascular endothelium in hypertension. Handb Exp Pharmacol 2006; 176(Pt. 2):249–283.
   PubMedGoogle Scholar
• Kuklinska AM, Mroczko B, Musial WJ, . Diagnostic biomarkers of essential arterial hypertension: the value of prostacyclin, nitric oxide, oxidized-LDL, and peroxide measurements. Int Heart J 2009; 50:341–351.
   PubMed Web of Science ®Google Scholar
• Zhang M, Yang Y, Yang X, Cai J. Human cytomegalovirus infection is a novel etiology for essential hypertension. Med Hypotheses 2011; 76:682–684.
   PubMed Web of Science ®Google Scholar
• Creager MA, Roddy MA. Effect of captopril and enalapril on endothelial dysfunction in hypertensive patients. Hypertension 1994; 24:499–505.
   PubMed Web of Science ®Google Scholar
• Kawanabe Y, Nauli SM. Endothelin. Cell Mol Life Sci 2011; 68:195–203.
   PubMed Web of Science ®Google Scholar
• Shankarishan P, Borah PK, Ahmed G, Mahanta J. Prevalence of endothelial nitric oxide synthase (eNOS) gene exon 7 Glu298Asp variant in North Eastern India. Indian J Med Res 2011; 133:487–491.
   PubMed Web of Science ®Google Scholar
• Kaplan NM, Victor RG, eds. Primary hypertension: pathogenesis. In: Kaplan’s Clinical Hypertension, 10th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2010, 42–107.
   Google Scholar
• Cossart YE, Field AM, Cant B, Widdows D. Parvovirus-like particles in human sera. Lancet 1975; 1:72–73.
   PubMed Web of Science ®Google Scholar
• Slavov SN, Kashima S, Pinto AC, Covas DT. Human parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions. FEMS Immunol Med Microbiol 2011; 62(3):247–262.
   PubMed Web of Science ®Google Scholar
• Naides SJ, Scharosch LL, Foto F, Howard EJ. Rheumatologic manifestations of human parvovirus B19 infection in adults. Initial two-year clinical experience. Arthritis Rheum 1990; 33:1297–1309.
   PubMed Web of Science ®Google Scholar
• Nesher G, Osborn TG, Moore TL. Parvovirus infection mimicking systemic lupus erythematosus. Semin Arthritis Rheum 1995; 24:297–303.
   PubMed Web of Science ®Google Scholar
• Servey JT, Reamy BV, Hodge J. Clinical presentations of parvovirus B19 infection. Am Fam Physician 2007; 75:373–376.
   PubMed Web of Science ®Google Scholar
• Takahashi M, Ito M, Sakamoto F, . Human parvovirus B19 infection: immunohistochemical and electron microscopic studies of skin lesions. J Cutan Pathol 1995; 22:168–172.
   PubMed Web of Science ®Google Scholar
• Nakazawa T, Tomosugi N, Sakamoto K, . Acute glomerulonephritis after human parvovirus B19 infection. Am J Kidney Dis 2000; 35:31.
   Web of Science ®Google Scholar
• Dingli D, Pfizenmaier DH, Arromdee E, . Severe digital arterial occlusive disease and acute parvovirus B19 infection. Lancet 2000; 356:312–314.
   PubMed Web of Science ®Google Scholar
• Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev 2002; 15:485–505.
   PubMed Web of Science ®Google Scholar
• Harel L, Straussberg R, Rudich H, Cohen AH, Amir J. Raynaud’s phenomenon as a manifestation of parvovirus B19 infection: case reports and review of parvovirus B19 rheumatic and vasculitic syndromes. Clin Infect Dis 2000; 30:500–503.
   PubMed Web of Science ®Google Scholar
• Murer L, Zacchello G, Bianchi D, . Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation. J Am Soc Nephrol 2000; 11:1132–1137.
   PubMed Web of Science ®Google Scholar
• Finkel TH, Török TJ, Ferguson PJ, . Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet 1994; 343:1255–1258.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, . Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206–1252.
   PubMed Web of Science ®Google Scholar
• Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990; 36:1440–1443.
   PubMed Web of Science ®Google Scholar
• Li S, Zhu J, Zhang W, . Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation 2011; 124:175–184.
   PubMed Web of Science ®Google Scholar
• Lip GH, Wise R, Beevers G. Association of Helicobacter pylori infection with coronary heart disease. Study shows association between H pylori infection and hypertension. BMJ 1996; 312:250–251.
   PubMed Web of Science ®Google Scholar
• Sun Y, Pei W, Wu Y, . Herpes simplex virus type 2 infection is a risk factor for hypertension. Hypertens Res 2004; 27:541–544.
   PubMed Web of Science ®Google Scholar
• Kristensen BO, Andersen PL, Vestergaard BF, Andersen HM. Herpesvirus antibodies and vascular complications in essential hypertension. Acta Med Scand 1982; 212:375–377.
   PubMed Web of Science ®Google Scholar
• Omura Y. Microbial infection or trauma at cardiovascular representation area of medulla oblongata as some of the possible causes of hypertension or hypotension. Acupunct Electrother Res 1988; 13:131–145.
   PubMed Web of Science ®Google Scholar
• Cook PJ, Lip GY, Davies P, . Chlamydia pneumoniae antibodies in severe essential hypertension. Hypertension 1998; 31:589–594.
   PubMed Web of Science ®Google Scholar
• Pitiriga VC, Kotsis VT, Alexandrou ME, . Increased prevalence of Chlamydophila pneumoniae but not Epstein-Barr antibodies in essential hypertensives. J Hum Hypertens 2003; 17:21–27.
   PubMed Web of Science ®Google Scholar
• Zabay JM, Marco J, Soler J, . Association of HLA-DRB3*0202 and serum IgG antibodies to Chlamydia pneumoniae with essential hypertension in a highly homogeneous population from Majorca (Balearic Islands, Spain). J Hum Hypertens 2005; 19:615–622.
   PubMed Web of Science ®Google Scholar
• Liu L, Liu Y, Tong W, . Pathogen burden in essential hypertension. Circ J 2007; 71:1761–1764.
   Google Scholar
• Weis M, Kledal TN, Lin KY, . Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis. Circulation 2004; 109:500–505.
   PubMed Web of Science ®Google Scholar
• Chen C, Chai H, Wang X, Lin PH, Yao Q. Chlamydia heat shock protein 60 decreases expression of endothelial nitric oxide synthase in human and porcine coronary artery endothelial cells. Cardiovasc Res 2009; 83:768–777.
   PubMed Web of Science ®Google Scholar
• Kern JM, Maass V, Rupp J, Maass M. Proliferative stimulation of the vascular Endothelin-1 axis in vitro and ex vivo by infection with Chlamydia pneumoniae. Thromb Haemost 2009; 102:743–753.
   PubMed Web of Science ®Google Scholar
• Virdis A, Ghiadoni L, Taddei S. Effects of antihypertensive treatment on endothelial function. Curr Hypertens Rep 2011; 13:276–281.
   PubMed Web of Science ®Google Scholar
• Tschöpe C, Bock CT, Kasner M, . High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 2005; 111:879–886.
   PubMed Web of Science ®Google Scholar
• Liu SC, Tsai CT, Wu CK, . Human parvovirus b19 infection in patients with coronary atherosclerosis. Arch Med Res 2009; 40:612–617.
   PubMed Web of Science ®Google Scholar
• Sodja I, Mrázová M, Smelhausová M, . Seroprevalence of IgG antibodies against parvovirus B19 in the population of the Czech Republic. Epidemiol Mikrobiol Imunol 1995; 44:171–174.
   PubMedGoogle Scholar
• Abraham M, Rudraraju R, Kannangai R, . A pilot study on the seroprevalence of parvovirus B19 infection. Indian J Med Res 2002; 115:139–143.
   PubMed Web of Science ®Google Scholar
• Heegaard ED, Petersen BL, Heilmann CJ, Hornsleth A. Prevalence of parvovirus B19 and parvovirus V9 DNA and antibodies in paired bone marrow and serum samples from healthy individuals. J Clin Microbiol 2002; 40:933–936.
   PubMed Web of Science ®Google Scholar